India is importing monoclonal antibodies from Australia to treat Nipah virus infection in Kerala. The drug, m102.4, was initially developed for treating Henipavirus. Early-stage trials have shown its potential in managing NiV, which has a high mortality rate of 40-70%.
September 16, 2023 at 03:43AM
from Times of India
https://ift.tt/SkB7WZi
India sources antibodies from Australia to fight Nipah virus
Subscribe to:
Post Comments (Atom)
It’s not just alcohol! 6 common habits are damaging your liver too
Many daily habits silently harm the liver. Excessive sugar intake causes fatty liver. Overusing painkillers strains liver function. Sedentar...
-
Several notable WWE veterans passed away in 2024, including Sika Anoa'i, Francisco Ciatso, Akebono, Ole Anderson, and Virgil. These wres...
-
Supreme Court on Tuesday rejected pleas for a retest for admissions to 1.08 lakh MBBS seats in govt and private medical colleges in the abse...
-
Horoscope Today: Read daily horoscope predictions for December 7, 2024. Know all about the astrological events and influences that will be a...
No comments:
Post a Comment